| Serial Number | 88000887 |
| Word Mark | PROFERO |
| Filing Date | Thursday, June 14, 2018 |
| Status | 606 - ABANDONED - NO STATEMENT OF USE FILED |
| Status Date | Monday, August 15, 2022 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, May 14, 2019 |
| Goods and Services | Testing kits comprised of medical diagnostic reagents and assays that test for the presence of certain genetic properties; Diagnostic agents, preparations and substances for medical purposes; Medical diagnostic reagents for the analysis of genetic material; Preparations for detecting changes in genes and gene expressions for medical purposes; Chemical reagents for medical analysis; Chemical preparation for use in medical analysis, particularly DNA analysis; Pharmaceutical preparations for diagnosis and for identifying and characterizing genetic abnormalities, tracking the progress of disease and measuring the effectiveness of therapies; Genetic identity tests comprises of reagents for medical purposes; Clinical diagnostic preparations for medical use |
| Goods and Services | Chemical test kits for genetic testing for laboratory or research use; Assays and reagents for use in genetic research; Diagnostic preparations for scientific or research use; Nucleic acid isolation and purification kit consisting primarily of reagents for scientific research purposes; Reagents for scientific or medical research use; Clinical diagnostic preparations for clinical or medical laboratory use |
| Translation of Words in Mark | The English translation of "PROFERO" in the mark is "DELAY". |
| Goods and Services | Medical diagnostic services in the field of molecular science, comparative genome analysis, nucleic acid arrays and screening of nucleic acids; Medical testing, analysis, and evaluation services for medical or diagnostic purposes for providing healthcare information; Providing health care information featuring information resulting from genomic research, testing, analysis, and evaluation; Diagnosis and treatment of medical conditions, namely, of cognitive, neurological, and brain-related conditions; Providing healthcare information; Providing information in the field of disease prevention, screening, diagnosis, and treatment for medical diagnostic and treatment purposes; Medical testing services for diagnostic or treatment purposes in the medical field; Proteogenomic profiling for diagnostic or treatment purposes of cognitive, neurological, and brain-related conditions; Identification of target molecules for disease treatment, namely, treatments of cognitive, neurological, and brain-related conditions |
| Goods and Services | Laboratory diagnostic services in the field of molecular science, comparative genome analysis, nucleic acid arrays and screening of nucleic acids; Medical and scientific research in the field of genetic testing and diagnosis and treatment of medical conditions; Development of tests and laboratory testing in the field of genetics and human disease; Scientific research consulting in the field of genetics, genomics, nucleic acid sequencing, and bioinformatics; Consulting services in the field of pharmaceutical research and development and laboratory testing; Genetic research, development and testing services; Genomic research, development and testing services for scientific research purposes; Nucleic acid collection, testing and analysis services for scientific research purposes; Genetic testing for scientific diagnostic research purposes; Genomic testing for scientific diagnostic research purposes; Medical and scientific research, development and consulting in the field of neurology; Medical and scientific research in the field of genetics and genetic engineering; Medical and scientific research and consulting in the fields of genomics and generation sequencing; Medical and scientific research in the field of disease treatment and diagnosis; Medical and scientific research relating to the design and development of treatment therapies; Data collection for research purposes, namely, the collection, testing and research of patient molecular and/or genomic data; Scientific clinical studies, namely, conducting clinical trials for others; Retrieval and correlation of genomic data for research or analysis purposes; Conducting clinical and pre-clinical trials; Targeted pharmaceutical drug development services; Genotyping services for research or analysis purposes; Gene screening for research or analysis purposes; Gene isolation and gene expression analysis for scientific and medical research purposes; Gene mapping; Gene analysis and biomarker discovery for scientific research and medical purposes; Research and development of identification and treatment methods for hereditary factors leading to disease; Nucleic acid-sequencing for scientific research purposes |
| International Class | 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. |
| US Class Codes | 001, 005, 006, 010, 026, 046 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, June 20, 2018 |
| Primary Code | 001 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, June 20, 2018 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, June 20, 2018 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, June 20, 2018 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | The Translational Genomics Research Institute |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Phoenix, AZ 85004 |
| Party Name | The Translational Genomics Research Institute |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Phoenix, AZ 85004 |
| Event Date | Event Description |
| Monday, August 15, 2022 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
| Monday, August 15, 2022 | ABANDONMENT - NO USE STATEMENT FILED |
| Thursday, January 13, 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Wednesday, January 12, 2022 | SOU EXTENSION 5 GRANTED |
| Wednesday, January 5, 2022 | SOU EXTENSION 5 FILED |
| Wednesday, January 12, 2022 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Wednesday, January 5, 2022 | TEAS EXTENSION RECEIVED |
| Tuesday, July 6, 2021 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Friday, July 2, 2021 | SOU EXTENSION 4 GRANTED |
| Friday, July 2, 2021 | SOU EXTENSION 4 FILED |
| Friday, July 2, 2021 | TEAS EXTENSION RECEIVED |
| Thursday, December 24, 2020 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Tuesday, December 22, 2020 | SOU EXTENSION 3 GRANTED |
| Tuesday, December 22, 2020 | SOU EXTENSION 3 FILED |
| Tuesday, December 22, 2020 | TEAS EXTENSION RECEIVED |
| Friday, July 3, 2020 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Wednesday, July 1, 2020 | SOU EXTENSION 2 GRANTED |
| Wednesday, July 1, 2020 | SOU EXTENSION 2 FILED |
| Wednesday, July 1, 2020 | TEAS EXTENSION RECEIVED |
| Wednesday, December 18, 2019 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Monday, December 16, 2019 | SOU EXTENSION 1 GRANTED |
| Monday, December 16, 2019 | SOU EXTENSION 1 FILED |
| Monday, December 16, 2019 | TEAS EXTENSION RECEIVED |
| Tuesday, July 9, 2019 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, May 14, 2019 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, May 14, 2019 | PUBLISHED FOR OPPOSITION |
| Wednesday, April 24, 2019 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Monday, April 1, 2019 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, March 13, 2019 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, March 13, 2019 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, March 11, 2019 | ASSIGNED TO LIE |
| Friday, March 8, 2019 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Monday, September 10, 2018 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Monday, September 10, 2018 | NON-FINAL ACTION E-MAILED |
| Monday, September 10, 2018 | NON-FINAL ACTION WRITTEN |
| Tuesday, September 4, 2018 | ASSIGNED TO EXAMINER |
| Wednesday, June 20, 2018 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| Monday, June 18, 2018 | NEW APPLICATION ENTERED IN TRAM |